REHOVOT, Israel, June 17 /PRNewswire/ --

- Expanded System Family First to Print Multiple Materials Simultaneously

Objet Geometries (http://www.objet.com/), the innovation leader in 3D printing, today launched the Connex350(TM), the company's second rapid prototyping system that allows product developers and manufacturers to simultaneously print multiple materials with different mechanical and physical properties. Modeled after Objet's groundbreaking Connex500(TM), the only other 3D printer in the world with this capability, the Connex350(TM) will debut on June 22-26 at the inaugural Time Compression Expo and Conference in Chicago and on June 23-24 at the Devcon 2009, Dassault Systems Developer Conference in Velizy, France.

ORLANDO, Florida, June 17 /PRNewswire/ --

- Groundbreaking Sixth Generation Platform Delivers Telepresence Over General Purpose Networks, Radically Simplifying Acquisition, Deployment and Operating Costs

- Total of 130 6G Telepresence Rooms Ordered in First 30 Days of General Availability

InfoComm -- Teliris (www.teliris.com), the leading global provider of agile telepresence and collaboration, today announced it has redefined the industry with the unveiling of 6G telepresence, an affordable platform that extends an uncompromised experience to locations anywhere in the world by reducing bandwidth and related costs.

SAN JOSE, California, June 17 /PRNewswire/ --

- Compromised PCs of Individuals and Corporations are Turned Into Digital Assets That Cybercriminals Potentially Trade Online. Traded Data Also Includes About 100,000 Stolen FTP Accounts

OSLO, Norway, June 17 /PRNewswire/ --

- New Investigational Drug Also Shown to Improve Remission Rates and Reduce Short-Term Mortality Compared to Previous Treatments

Clavis Pharma ASA (OSE: CLAVIS) today announces positive final results from a Phase II trial of its novel investigational cancer drug, elacytarabine (CP-4055), in patients with late-stage acute myeloid leukaemia (AML). In the trial, elacytarabine showed statistically significant superior efficacy compared to published clinical data for late-stage AML. Based on these encouraging results an elacytarabine registration study is being planned.

LONDON, June 17 /PRNewswire/ --

- White Paper Highlights Mobile Unified Communications Value Added Services for Mobile Network Operators to Deliver Mobile Office Capabilities and Increased ARPU

Frost Sullivan whitepaper highlights how a range of factors including good client design can be fundamental to increasing value added services through the uptake of Unified Communications (UC) by both consumer and enterprise users and obtaining increased ARPU - average revenue per user - for ISPs and mobile network operators in providing value added services http://www.communigate.com .

LONDON, June 17 /PRNewswire/ -- Small business bosses are crying out for new recruits with work-related skills, according to research released in the run up to VQ Day 2009, the national celebration of vocational achievement taking place on 24th June.

The research by independent education foundation Edge found that three-quarters (75 per cent) of people running small and medium enterprises (SMEs) feel there is a mis-match between young people's skills and the requirements of their organisation. Almost as many - 71 per cent - believe the job market contains too few people with vocational qualifications and practical skills, and two thirds believe every young person should study at least one vocational qualification at school.

HERZLIA, Israel, June 17 /PRNewswire/ --

- Revenue-Generating Service Enables Parents to Customize Access to Inappropriate Video and Web Content

Flash Networks, a global provider of intelligent mobile Internet solutions, announced today the availability of Content Control 2.0, a policy-based solution that includes new functionality enabling parents to pick and choose the content they consider to be inappropriate or dangerous and how filtering should be applied for each family member. These new user-customization features transform content control from a basic black-list service to a revenue-generating solution and a key differentiator for mobile operators.

SUNNYVALE, California, June 17 /PRNewswire/ --

- Oncology Test Further Highlights Broad Market Applicability of GeneXpert System

Cepheid (Nasdaq: CPHD) today announced the release of its improved Xpert(R) BCR-ABL Monitor test to be marketed as a CE IVD product under the European Directive on In Vitro Diagnostic Medical Devices. With improved time-to-results, the test now detects the BCR-ABL chromosomal translocation in about 2 hours as compared to 2.5 hours for the original product release. The test is intended to aid European clinicians in the monitoring of patients with Chronic Myelogenous Leukemia (CML). The test runs on Cepheid's GeneXpert(R) System, the world's leading on-demand molecular diagnostic platform.

STOCKHOLM, June 17 /PRNewswire/ -- Finding new locations for radio base stations is a growing challenge, especially in urban and suburban areas. Ericsson's (NASDAQ:ERIC) new solution addresses this challenge by being as eye-catching, or as unobtrusive, as required in order to shorten the time to obtain building permission from authorities. The site is designed by renowned Scandinavian architect Thomas Sandell.

To view the Multimedia News Release, please click:

http://www.prnewswire.com/mnr/ericsson/38829/

MORRISTOWN, New Jersey, June 17 /PRNewswire/ --

- Arrow Will Expand Watson's Global Commercial Footprint

- Transaction Expected to be Accretive to Cash Earnings Per Share in 2010 Before Synergies

- Enhances Watson's Long Term Growth Profile